DBV Technologies To Present At Upcoming US Investors Conferences
6/17/2014 9:13:11 AM
BAGNEUX, France, June 16, 2014 - DBV Technologies, (Euronext: DBV - ISIN: FR0010417345), creator of Viaskin®, a new paradigm for the treatment of food allergies, today announced that members of the company's management team will present at two upcoming investors conferences in New York City, USA, in June.
Help employers find you! Check out all the jobs and post your resume.
comments powered by